Difference between revisions of "NCCN guidelines"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 6: Line 6:
  
 
[[Category:General reference pages]]
 
[[Category:General reference pages]]
 +
 +
*'''2003:''' Unknown et al. [https://doi.org/10.6004/Jnccn.2003.0026 Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768886/ PubMed]
 +
*'''2015:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2015.0105 Breast Cancer Risk Reduction, Version 2.2015.] [https://pubmed.ncbi.nlm.nih.gov/26150582/ PubMed]
 +
*'''2003:''' Unknown et al. [https://doi.org/10.6004/Jnccn.2003.0023 Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/19768883/ PubMed]
 +
*'''2018:''' Bevers et al. [https://doi.org/10.6004/Jnccn.2018.0083 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.] [https://pubmed.ncbi.nlm.nih.gov/30442736/ PubMed]

Revision as of 19:40, 29 November 2023

This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Miscellaneous